Personalized breast radiation based on risk and side effects
Part of Cancer, Skin clinical trials.
This trial tests whether radiation therapy can be personalized based on your risk of the cancer coming back and your risk of side effects from radiation. Depending on those factors, you may receive a tailored radiation plan that could be more or less intense.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman 18 or older with invasive breast cancer.
- You have had either a lumpectomy or mastectomy, and your doctor recommends radiation therapy to the breast or chest wall.
- Your cancer has not spread to other parts of the body (no distant metastases).
- You cannot have had radiation to the same breast before, or have other active cancers (except certain skin or cervical cancers).
- You will need to have a blood or urine pregnancy test if you could become pregnant, and use effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses individual measures of how sensitive your body’s tissues are to radiation to guide after-surgery breast radiation treatment. It aims to keep treatment safe and effective while tailoring the plan to each person.
This trial tests a new way to deliver radiation therapy that adapts to each patient's body changes during treatment. It is for women who had breast cancer surgery and need radiation to the whole breast and nearby lymph nodes, and who have been identified as being at risk for breast fibrosis.
This trial tests a short, more intense radiation schedule for women with certain breast cancer types or who are under 40. It aims to reduce treatment time while still targeting the whole breast and any high-risk areas.
This trial studies a tailored form of radiation treatment for some people with early breast cancer whose sentinel lymph-node biopsy shows cancer in 1–2 nodes. It may help improve local control while guiding the best radiation approach for your specific situation.
This study is looking for biomarkers (genetic clues) to predict how patients will react to radiation after breast-conserving surgery. It aims to create a model that can personalize treatment to reduce side effects.
This trial tests a shorter, more targeted course of daily radiation for early-stage breast cancer. The radiation plan is adjusted each day to better fit your body, which may reduce side effects.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.